Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 2Phase 1/2 1

Status

Terminated 6Completed 5Withdrawn 1

Sponsor Class

INDUSTRY 3OTHER 1NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 3Tumor-Agnostic 1Thoracic 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumors 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced or Recurrent Solid Tumors 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Completed × vadimezan × Clear all
NCT00674102 2020-12-09

An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)

Novartis

Phase 1 Completed
15 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01285453 2020-12-09

Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors

Novartis

Phase 1 Completed
9 enrolled
Other solid neoplasm

Advanced or Recurrent Solid Tumors

NCT00003697 2013-12-19

Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
3 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00863733 2009-03-18

DMXAA

Cancer Research UK

Phase 1 Completed
63 enrolled
Other solid neoplasm

Solid Tumors

NCT00856336 2009-03-05

DART

Antisoma Research

Phase 1 Completed
15 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡